The Technion’s story has been intertwined with Israel’s for more than a century, from laying the foundations for a new nation to shaping its future.
From medicine to security, explore how the Technion is advancing Israel and improving lives around the world.
View All Impact Areas
Explore stories, news, insights, and data across articles, videos, and podcasts.
view all content types
companies founded by graduates and faculty in the last 10 years
locations
among universities worldwide for producing undergrad entrepreneurs
The Technion’s story has been intertwined with Israel’s for more than a century, from laying the foundations for a new nation to shaping its future.
Explore ATS, the Technion, and the people behind the breakthroughs redefining what's possible for Israel and the world.
Learn More About ATSATS is a community of supporters, innovators, and champions of possibility united by one mission: transforming Israel and the world through science and discovery.
Learn MoreFor more than 100 years, the Technion has been Israel's technological engine and leading driver of innovation, technology, and entrepreneurship, transforming ideas into impact.
Learn More
Step inside Israeli innovation at the David and Janet Polak Visitors Center. Experience our 360° immersive movie and tech exhibition. Open to individuals and groups.
Learn MoreFrom medicine to security, explore how the Technion is advancing Israel and improving lives around the world.
View All Impact AreasExplore stories, news, insights, and data across articles, videos, and podcasts.
view all content typesExplore ATS, the Technion, and the people behind the breakthroughs redefining what's possible for Israel and the world.
Learn More About ATS
Assistant Professor Meytal Landau is a member of the Technion Faculty of Biology. Her research focuses on protein structure-function relationships to better understand diseases and how to treat them. Of particular focus to Prof. Landau is understanding how to fight antibiotic-resistant bacteria. Her lab is also studying rational drug design in order to move drugs to the market more quickly.
Prof. Landau holds three patents and has published more than 40 papers in professional journals. She has received more than 20 awards and honors, including the Biophysical Society’s Margaret Oakley Dayhoff Award (2019), the Wolf Foundation’s Krill Prize for Excellence in Scientific Research (2018), the Excellence in Research Award from the Henry Gutwirth Fund for the Promotion of Research (2018), and the Alon Fellowship from the Israeli Council for Higher Education.
Pictured Above / (L to R) Professor Meytal Landau, Professor Asya Rolls, Professor Avi Schroeder, Assistant Professor Graham de Ruiter, and Professor Nadav Amdursky Recently, five researchers from the Technion were awarded prestigious Consolidator Grants by the European Research Council (ERC) for unique projects in their respective disciplines. The ERC Consolidator Grants provide $2.14 million to each recipient and are awarded to scientists with 7-12 years of postdoctoral research experience to fund their explorations and allow them to pursue their most promising ideas. The five Technion recipients are: Associate Professor Nadav Amdursky, a researcher in the Schulich Faculty of Chemistry…
For newly minted Ph.D.s, choosing where to plant their academic roots can be an overwhelming decision. It shapes the direction of their research, where they live, and with whom they collaborate. The choice is also key for universities, which rely on recruiting top faculty to attract the best students. That’s why the Technion has long […]
Bringing these diverse fields together under one roof is intended to shorten the journey from discovery to application, creating an environment where medical needs can spark new research and promising innovations can move more quickly toward the patients who need them. “The combination of a research hospital and a technological university provides the entire value […]
Stay on top of the latest breaking scientific discoveries from Israel and the Technion. Subscribe to the ATS newsletter.